Medtronic’s cash flow outlook, earnings discount, and expanding medical technology portfolio shape a balanced valuation ...
A product image of the Flex insulin pump with the Simplera Sync sensor. [Image courtesy of MiniMed] MiniMed (Nasdaq:MMED) announced today that Medicare and Medicare Advantage beneficiaries now have ...
MiniMed , a global leader in diabetes technology, today announced that Medicare and Medicare Advantage beneficiaries now have ...
Medtronic (NYSE:MDT) has completed its acquisition of SPR Therapeutics. The deal adds a minimally invasive, non opioid ...
In May 2026, Medtronic voluntarily initiated a Class II recall of 590 Octopus 4 Tissue Stabilizer devices after discovering ...
Leeds Teaching Hospitals is also set to expand its use of artificial intelligence (AI) in healthcare following a £1.5 million ...
Medical device manufacturer Medtronic went on trial on Wednesday in the first case to reach a jury out of thousands of ...
The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...
Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and ...
Leeds has been chosen as the UK base for a major European research initiative aiming to transform how diabetes is treated in ...
Dexcom G7 15 Day is the longest‑lasting and most accurate 1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days 5. BURNABY, British ...
Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results